EudraVigilance for TOZINAMERAN (Pfizer) (up to 23/01/2021)
https://dap.ema.europa.eu/analytics/saw.dll?PortalPages&PortalPath=%2Fshared%2FPHV%20D AP%2F_portal%2FDAP&Action=Navigate&P0=1&P1=eq&P2=% 22Line%20Listing%20Objects%22.%22Substance%20High% 20Level%20Code%22&P3=1+42325700
Nervous system disorders: 25 dödsfall
Vascular disorders: 11 Dödsfall
Respiratory, thoracic and mediastinal disorders: 42 dödsfall
Renal and urinary disorders: 8 dödsfall
Metabolism and nutrition disorders: 9 dödsfall
Injury, poisoning and procedural complications: 8 dödsfall
Infections and infestations: 34 dödsfall
Immune system disorders: 3 dödsfall
General disorders and administration site conditions: 173 dödsfall
Gastrointestinal disorders: 21 dödsfall
Congenital, familial and genetic disorders: 1 dödsfall
Cardiac disorders: 63 dödsfall
Blood and lymphatic system disorders: 6 dödsfall